GGrantIndex
Sort

16,300 grants matching fatty liver disease

Building Mouse Models of Metabolic Syndrome

$373,152
Karen L Svenson · Jackson Laboratory · R01 · FY2012 · DK

Fatty Acid Desaturase 1 (FADS1) Variants and Non-alcoholic Fatty Liver Disease

$373,090
Wanqing Liu · Wayne State University · R01 · FY2020 · DK

The Physiological Relevance of SIRT1 in Brain on Energy and Glucose Homeostasis

$373,032
Roberto Coppari · Ut Southwestern Medical Center · R01 · FY2010 · DK

Caspase Dependent Cell Death in Nonalcoholic Fatty Liver Disease

$373,032
Ariel Feldstein · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · DK

Structure and Function of Mitochondrial Protein Kinases

$373,032
David T Chuang · Ut Southwestern Medical Center · R01 · FY2010 · DK

Regulation of Metabolism by the Hormone FGF15/19

$373,032
Steven A Kliewer · Ut Southwestern Medical Center · R01 · FY2010 · DK

THE ROLE OF CARDIOLIPIN IN THE TCA CYCLE: IMPLICATIONS FOR BARTH SYNDROME

$372,996
Miriam L Greenberg · Wayne State University · R01 · FY2020 · HL

Regulation of lipid synthesis in estrogen receptor positive breast cancer

$372,890
Jonna Frasor · University Of Illinois At Chicago · R01 · FY2015 · CA

Role of Adipose in Ethanol-Induced Tissue Injury

$372,875
Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R37 · FY2009 · AA

Fatty Acid Desaturase 1 (FADS1) Variants and Non-alcoholic Fatty Liver Disease

$372,803
Wanqing Liu · Wayne State University · R01 · FY2019 · DK

IGF-I' S INFLUENCE ON PRE-ADIPOCYTES

$372,698
James L. Kirkland · Southern Illinois University Sch Of Med · P01 · FY2011 · AG

Fatty liver in HIV infected individuals

$372,678
Samer Gawrieh · Indiana University Indianapolis · R01 · FY2017 · DK

Regulation of lipid synthesis in estrogen receptor positive breast cancer

$372,653
Jonna Frasor · University Of Illinois At Chicago · R01 · FY2016 · CA

Lymphotoxin/LIGHT in Lipoprotein Metabolism and Atherosclerosis

$372,621
Godfrey Shalom Getz · University Of Chicago · R01 · FY2007 · HL

Bariatric Surgery for Morbid Obesity: Clinical and Pathophysiologic Consequences

$372,575
Paul David Berk · Columbia University Health Sciences · R01 · FY2006 · DK

Neuroendocrine Regulation of Adipocyte Metabolism

$372,518
Matthias H Tschop · University Of Cincinnati · R01 · FY2010 · DK

THE ROLE OF CARDIOLIPIN IN THE TCA CYCLE: IMPLICATIONS FOR BARTH SYNDROME

$372,516
Miriam L Greenberg · Wayne State University · R01 · FY2021 · HL

Cholesterol Ester Hydrolysis and cholesterol efflux

$372,500
Shobha Ghosh · Virginia Commonwealth University · R01 · FY2008 · HL

Fibrin(ogen) control of metabolic inflammation and obesity

$372,318
Matthew J. Flick · Univ Of North Carolina Chapel Hill · R01 · FY2021 · DK

Embryonic origin and self-renewal of B-1a cells

$372,180
Momoko Yoshimoto · University Of Texas Hlth Sci Ctr Houston · R01 · FY2019 · AI

CYP2B6 inhibitors perturb proper distribution of lipids leading to obesity and fatty liver disease

$372,110
William S Baldwin · Clemson University · R15 · FY2020 · ES

THE ROLE OF CARDIOLIPIN IN THE TCA CYCLE: IMPLICATIONS FOR BARTH SYNDROME

$372,017
Miriam L Greenberg · Wayne State University · R01 · FY2022 · HL

Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis

$372,013
Natalia Nieto · University Of Illinois At Chicago · U01 · FY2015 · AA

NKT cells in lipoprotein Metabolism and atherosclerosis

$371,980
Godfrey Shalom Getz · University Of Chicago · R01 · FY2008 · HL

MECHANISMS FOR FETAL HEPATIC PROGRAMMING IN THE NON-HUMAN PRIMATE (NHP)

$371,956
Jacob E Friedman · University Of Colorado Denver · R01 · FY2010 · DK